|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
From June 2012 to July 2014, participants completed the Impact of Event Scale (IES) and Depression (DEP) and Anxiety (ANX) subscales of the Symptom CheckList-90-R (SCL-90) every 6 weeks.
|
28606893 |
2017 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
<b>Objective</b>: This study examined the construct validity of two widely-used instruments for the assessment of PTSD symptoms (Harvard Trauma Questionnaire [HTQ]; 16 items) and symptoms of anxiety and depression (Hopkins Symptom Check list-25 [HSCL-25]; 25 items) among Dutch and refugee patients with different linguistic backgrounds.
|
29038686 |
2017 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
All abbreviated forms were strongly correlated with the SCL-90-R for general psychopathology (r = 0.93-0.99), depression (r = 0.89-0.95), anxiety (r = 0.97-0.98), psychosis (r = 0.95-0.99), and obsessive-compulsive symptoms (r = 0.97).
|
31665694 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The results from the current study supported the use of the SCL-10 and WHO-5 as potential PROMs to capture symptom burden and quality of life within groups of people with anxiety or depression undergoing psychotherapy treatment.
|
29546787 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this longitudinal study, 27 lung transplant recipients were prospectively examined for psychological distress (Symptom Checklist short version-9; SCL-K-9), health-related quality of life (EuroQOL five dimensions questionnaire; EQ-5D), depression (HADS-Depression scale), and socio-demographic and medical outcomes at two weeks, three months, six months and three years following LTx.
|
30961347 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A wide neuropsychiatric battery was employed including the following: symptoms checklist 90-R (SCL-90-R), Toronto alexithymia scale (TAS-20), Hamilton anxiety rating scale (HAMA), Beck depression inventory (BDI II), dissociative experiences scale (DES), traumatic experience checklist (TEC), somatoform dissociation questionnaire (SDQ-20), and temperament and character inventory-revised (TCI-R).
|
29092782 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Affective symptoms were measured at baseline and at four follow-ups using SCL-90 anxiety and depression subscales.
|
20064128 |
2010 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Moreover, compared with the short-term prisoners, mindfulness training was more effective on the long-term prisoners in mindfulness level (<i>p</i> < .05), SCL-90 (<i>p</i> < .001), anxiety (<i>p</i> < .05), depression (<i>p</i> < .05), aggression (<i>p</i> < .05), total mood disturbance (<i>p</i> < .0l), and perceived stress (<i>p</i> < .0l).
|
31043102 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
All of the subjects completed a uniform clinical evaluation that included the Unified Huntington's Disease Rating Scale-99, molecular testing to determine HD mutation status, the SCL-90-R, and the Center for Epidemiological Studies Depression Scale.
|
17210818 |
2007 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Forty-three subjects (77%) evidenced mild depression of which 13 (23%) reported moderate-severe symptoms by the Beck Depression Inventory--a finding confirmed with Hamilton Rating Scale for Depression and the SCL-90-D scale.
|
2934456 |
1985 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Individuals were assessed cross-sectionally for depression (PHQ-9), anxiety (GAD-7), post-traumatic stress disorder symptoms (PDS), somatic syndrome (SCL-90-R), alcohol dependence (ICD-10), functional impairment (PDS life functioning section), and self-perceived general physical health (SF-36).
|
31463614 |
2020 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Anxiety and depression were measured using the HSCL-25, and condom use and sexual partner concurrency were assessed through self-report.
|
29156358 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Symptoms of anxiety and depression were assessed by the Hopkins Symptom Checklist-25 (HSCL-25), somatization was assessed by the Somatization Subscale of the Symptom-Checklist-90 (SCL-90), and the number of witnessed and experienced trauma was assessed by the Posttraumatic Diagnostic Scale (PDS/HTQ).
|
31088419 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mothers reported symptoms of anxiety and depression three times during pregnancy (at 13.3 ± 1.1, 20.2 ± 1.5, and 33.8 ± 1.5 weeks of pregnancy, respectively) using the anxiety subscale of the Symptom Checklist (SCL-90), the Spielberger State and Trait Anxiety Inventory (STAI), and the Edinburgh Postnatal Depression Scale (EPDS).
|
29902667 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Demographics, lung function, anxiety (anxiety subscale of the 90-item symptom checklist (SCL-90-A)), depression (Beck depression inventory for primary care (BDI-PC)), exercise tolerance (six-minute walking distance test (6MWD)), and health status (Nijmegen clinical screening instrument (NCSI)) were assessed before and after a 12-week PR programme.
|
31434343 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Individual's completed measures of perfectionism (Frost-MPS), Emotional Inhibition (EIS), Depression (BDI-II), Anxiety (STAI-Y), Global symptoms (SCL-90-R), and interpersonal problems (IIP-32).
|
29621675 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Significant negative or positive correlations were observed between GH-IGF-1 concentrations and impairments on several EDI-2 subscales (drive for thinness, body dissatisfaction, interoceptive awareness, sense of ineffectiveness, interpersonal distrust, maturity fear) and on SCL-90 subitems (depression, hostility, obsessivity compulsivity, anxiety), suggesting a possible hormonal modulatory effect on specific aspects of ED psychopathology.
|
29179911 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Anxiety and depression were measured using the HSCL-25 and condom use and sexual partner concurrency were assessed through self-report.
|
29168066 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Among adolescents, those on EFV had lower scores on depression (HADS (Cohen's D: 0.3; P = 0.02) and SCL-90 (Cohen's D: 0.1; P = 0.02).
|
29220120 |
2018 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We found differences between the eutocic and instrumental delivery groups in the SCL-90-R subscales somatisation (t = 6.98; p = 0.01), anxiety (t = 3.42; p < 0.05), depression (t = 5.20; p < 0.02) and psychoticism (t = 5.28; p < 0.01), and in the general indices global severity index (t = 5.57; p < 0.05) and positive symptoms (t = 5.21; p < 0.01).
|
31254963 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The primary outcome measure was severity of PTSD-symptoms (Harvard Trauma Questionnaire (HTQ)) and secondary outcome measures were depression and anxiety symptoms (Hopkins Symptom Checklist-25 (HSCL-25), Hamilton Depression and Anxiety rating scales (HAM-D, HAM-A)), somatisation (somatisation items of SCL-90 (SI-SCL-90)), quality of life (WHO-5-Well-being Index (WHO-5)) and functioning (Sheehan Disability Scale (SDS), Global Assessment of Functioning (GAF-F, GAF-S)).
|
30791342 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The comparison of the patient and control groups based on SCL-90-R findings demonstrated that the patient group scores in somatization, anxiety (p = 0.000), depression (p = 0.003), anger (p = 0.02), interpersonal sensitivity (p = 0.006), phobia (p = 0.001), paranoid thoughts (p = 0.012), psychosis (p = 0.031) subscales and additional subscale (p = 0.014) and general symptom index (p = 0.001) scores were higher.
|
30472336 |
2019 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The effect of childhood adversity was significantly moderated by genetic vulnerability for depression in the model of both follow-up psychotic experiences (SCL-90-R) and follow-up psychotic trait liability (CAPE).
|
21835094 |
2012 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Compared to the control group, the intervention group demonstrated significantly greater improvement in the Arnetz and Hasson stress score (AHSS, p = 0.019), the total Symptoms Checklist 8 score (SCL-8D, p = 0.037), the SCL-8D anxiety sub-score (p = 0.017), and on a summarized feedback score (p = 0.026), but not on the depression subscale.
|
28028732 |
2017 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Statistically higher SCL-90-R scores were found in active patients for obsessive-compulsive disorder (P = 0.026), depression (P = 0.013), anxiety (P = 0.013), phobic anxiety (P = 0.002), psychoticism (P = 0.007), global severity index (GSI) (P = 0.005) and positive symptom total (PST) (P = 0.001).
|
30689871 |
2019 |